Who owns NOVABAY PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Novabay Pharmaceuticals stock

Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
BlackRock 1.8M $10M 100% Dec 2025
 View chart
Vanguard Group 1.8M $10M 2065% Dec 2025
 View chart
Geode Capital Management 1.3M $7.1M 2332% Dec 2025
 View chart
State Street Corporation 314k $1.8M 971% Dec 2025
 View chart
Northern Trust 274k $1.5M 100% Dec 2025
 View chart
Goldman Sachs Group 104k $589k 100% Dec 2025
 View chart
Charles Schwab Investment Management 93k $526k 100% Dec 2025
 View chart
Jane Street 70k $395k 100% Dec 2025
 View chart
Susquehanna International 47k $264k 100% Dec 2025
 View chart
C2C Wealth Management 45k $254k 100% Dec 2025
 View chart
Qube Research & Technologies 41k $230k 100% Dec 2025
 View chart
UBS Group 34k $190k 100% Dec 2025
 View chart
Apollon Wealth Management 28k $155k 0% Dec 2025
 View chart
Bank of New York Mellon 26k $146k 100% Dec 2025
 View chart
OMERS Administration Corporation 21k $120k 100% Dec 2025
 View chart
ExodusPoint Capital Management 20k $114k 100% Dec 2025
 View chart
Atomi Financial Group 17k $95k 100% Dec 2025
 View chart
Victory Capital Management 14k $81k 100% Dec 2025
 View chart
Tower Research Capital 3.0k $17k 215% Dec 2025
 View chart
NVWM 3.00 $17.000100 0% Dec 2025
 View chart
Addison Advisors 1.00 $6.000000 0% Dec 2025
 View chart
Northwestern Mutual Wealth Management Company 1.00 $6.000000 0% Dec 2025
 View chart
Royal Bank of Canada 1.00 $0 0% Sep 2025
 View chart

Who sold out of Novabay Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Ground Swell Capital Sep 2025 19k $25k
Virtu Financial Sep 2025 11k $14k